Uploaded December 2025 | Updated September 2026, 1 day ago
Our speakers:
Dr. Chumkee Aziz, Outreach Veterinarian, UC Davis Koret Shelter Medicine Program
Dr. Lucy Fuller, Chief of Medical Officer, Charleston Animal Society
Dr. Biana Tamimi, Director of Shelter Medicine, NYC Animal Care & Control
This panel discussion will examine the use of Elanco’s Canine Parvovirus Monoclonal Antibody (CPMA) therapy in animal shelter settings, featuring insights from veterinarians who have implemented CPMA on the ground in cats and dogs. Panelists will discuss the practical considerations, including resource allocation, staff training, and the impact of CPMA on high-risk populations. They will share real-world experiences with treatment protocols, decision-making around patient selection, and how CPMA fits into broader parvovirus management strategies. The session will emphasize key outcomes, lessons learned, and practical recommendations to support shelters considering this therapy.
About Community Conversations, hosted by Maddie’s Fund: When the COVID-19 pandemic hit in early 2020, animal sheltering transformed overnight. Foster-based sheltering, home-based employees and volunteers, along with collaboration galvanized our communities. The pandemic, along with social injustice, has motivated our industry to look at how we partner with our communities and confront our own biases. Shelter and rescue staff across the country began talking on a weekly basis, offering support and innovative ideas to do things differently. To learn more about these calls, visit forum.maddiesfund.org/communityconversations
To access today’s recording of this call - or to ask questions - visit https://maddies.fund/communityconversations121525
Chapters:
00:00 Welcome, Question of the Day
03:44 Presentation
Our speakers:
Dr. Chumkee Aziz, Outreach Veterinarian, UC Davis Koret Shelter Medicine Program
Dr. Lucy Fuller, Chief of Medical Officer, Charleston Animal Society
Dr. Biana Tamimi, Director of Shelter Medicine, NYC Animal Care & Control
This panel discussion will examine the use of Elanco’s Canine Parvovirus Monoclonal Antibody (CPMA) therapy in animal shelter settings, featuring insights from veterinarians who have implemented CPMA on the ground in cats and dogs. Panelists will discuss the practical considerations, including resource allocation, staff training, and the impact of CPMA on high-risk populations. They will share real-world experiences with treatment protocols, decision-making around patient selection, and how CPMA fits into broader parvovirus management strategies. The session will emphasize key outcomes, lessons learned, and practical recommendations to support shelters considering this therapy.
About Community Conversations, hosted by Maddie’s Fund: When the COVID-19 pandemic hit in early 2020, animal sheltering transformed overnight. Foster-based sheltering, home-based employees and volunteers, along with collaboration galvanized our communities. The pandemic, along with social injustice, has motivated our industry to look at how we partner with our communities and confront our own biases. Shelter and rescue staff across the country began talking on a weekly basis, offering support and innovative ideas to do things differently. To learn more about these calls, visit forum.maddiesfund.org/communityconversations
To access today’s recording of this call - or to ask questions - visit https://maddies.fund/communityconversations121525
Chapters:
00:00 Welcome, Question of the Day
03:44 Presentation
